-57.2%
COIN vs MRNA
+909.7%
-966.8%
-57.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.7% | -6.5% | -3.1% | -9.0% |
| 7D | -14.8% | +8.4% | -23.2% | -15.4% |
| 30D | -26.3% | +28.8% | -55.1% | -28.2% |
| 3M | -8.7% | +329.2% | -337.9% | -29.0% |
| 6M | -30.8% | +416.9% | -447.7% | -51.4% |
| YTD | -39.5% | +718.8% | -758.3% | -63.7% |
| 1Y | -57.2% | +924.9% | -982.0% | -77.1% |
| All | -57.2% | +909.7% | -966.8% | -77.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling